Faries DE - Search Results

1

Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.

Liu X, Cui Z, Niu L, Faries DE, Ball T, Johnstone B. Liu X, et al. Among authors: faries de. Clin Ther. 2011 Nov;33(11):1726-38. doi: 10.1016/j.clinthera.2011.09.027. Epub 2011 Oct 22. Clin Ther. 2011. PMID: 22019345

2

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. Ascher-Svanum H, et al. J Clin Psychiatry. 2006 Jul;67(7):1114-23. doi: 10.4088/jcp.v67n0715. J Clin Psychiatry. 2006. PMID: 16889456 Clinical Trial.

3

Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.

Liu X, Gelwicks S, Faries DE, Able SL. Liu X, et al. Among authors: faries de. Int Clin Psychopharmacol. 2010 Nov;25(6):315-22. doi: 10.1097/YIC.0b013e32833db42e. Int Clin Psychopharmacol. 2010. PMID: 20706125

4

Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.

Cui Z, Faries DE, Zhao Y, Novick D, Liu X. Cui Z, et al. Among authors: faries de. J Med Econ. 2011;14(5):662-72. doi: 10.3111/13696998.2011.611060. Epub 2011 Sep 5. J Med Econ. 2011. PMID: 21892857 Free article.

5

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder.

Liu X, Chen Y, Faries DE. Liu X, et al. Among authors: faries de. Clinicoecon Outcomes Res. 2011;3:63-72. doi: 10.2147/CEOR.S17846. Epub 2011 Mar 15. Clinicoecon Outcomes Res. 2011. PMID: 21935334 Free PMC article.

6

Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective.

Cui Z, Faries DE, Gelwicks S, Novick D, Liu X. Cui Z, et al. Among authors: faries de. J Med Econ. 2012;15(1):134-44. doi: 10.3111/13696998.2011.632043. Epub 2011 Nov 2. J Med Econ. 2012. PMID: 22014076 Free article.

7

Predictors of duloxetine adherence and persistence in patients with fibromyalgia.

Cui Z, Zhao Y, Novick D, Faries D. Cui Z, et al. J Pain Res. 2012;5:193-201. doi: 10.2147/JPR.S31800. Epub 2012 Jun 22. J Pain Res. 2012. PMID: 22792005 Free PMC article.

8

Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetine.

Cui Z, Faries DE, Shen W, Able SL, Novick D. Cui Z, et al. Among authors: faries de. J Med Econ. 2013;16(5):623-32. doi: 10.3111/13696998.2013.778267. Epub 2013 Mar 5. J Med Econ. 2013. PMID: 23425292 Free article.

9

Propensity score matching and subclassification in observational studies with multi-level treatments.

Yang S, Imbens GW, Cui Z, Faries DE, Kadziola Z. Yang S, et al. Among authors: faries de. Biometrics. 2016 Dec;72(4):1055-1065. doi: 10.1111/biom.12505. Epub 2016 Mar 17. Biometrics. 2016. PMID: 26991040

10

Propensity score matching for estimating a marginal hazard ratio.

Wang T, Zhao H, Yang S, Tang S, Cui Z, Li L, Faries DE. Wang T, et al. Among authors: faries de. Stat Med. 2024 Jun 30;43(14):2783-2810. doi: 10.1002/sim.10103. Epub 2024 May 5. Stat Med. 2024. PMID: 38705726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters